Munachiso N.
- Country
- Czechia
- Department
- Department of Obstetrics and Gynecology
Research Overview
- Sacituzumab Tirumotecan With or Without Bevacizumab Versus Standard of Care in Patients With Newly Diagnosed Advanced HRD-Negative Ovarian Cancer Following Platinum-Based Chemotherapy
- Phase 3 Randomized Study of Rinatabart Sesutecan + Bevacizumab vs Bevacizumab in Recurrent Platinum‑Sensitive Ovarian Cancer after Second‑Line Platinum Doublet
- Evaluation of Adjuvant Therapy with Carboplatin and Cisplatin in Early-Stage, Intermediate-Risk Cervical Cancer Post-Radical Surgery
Data & Insights
Has run more than one trial at 68 of 192 partner sites.
Specializations
Hematologic Malignancies
Munachiso Ndukwe is involved in clinical research across a broad range of blood cancers, with a strong emphasis on lymphoma, leukemia, and multiple myeloma. The portfolio includes relapsed and refractory settings as well as newly diagnosed disease, reflecting a focus on therapeutic innovation in difficult-to-treat hematologic disorders.
- Follicular lymphoma
- Chronic lymphocytic leukemia
- Diffuse large B-cell lymphoma
- Multiple myeloma
- Myelodysplastic syndromes
Additional interests include mantle cell lymphoma, marginal zone lymphoma, Hodgkin lymphoma, and Waldenström macroglobulinemia, with activity spanning both aggressive and indolent B-cell malignancies.
Genitourinary and Gynecologic Oncology
The investigator is active in trials for urothelial carcinoma, bladder cancer, renal cell carcinoma, prostate cancer, breast cancer, ovarian cancer, and cervical cancer. This area reflects a therapeutic interest in advanced solid tumors and treatment-resistant disease across multiple oncologic subtypes.
- Urothelial carcinoma
- Renal cell carcinoma
- Prostate cancer
- Breast cancer
- Ovarian cancer
Research activity also extends to endometrial cancer, gastric cancer, and colorectal cancer, indicating engagement with targeted and immunotherapy-based approaches in solid tumor care.
Immune-Mediated and Inflammatory Disease
Munachiso Ndukwe contributes to studies in multiple sclerosis, Crohn's disease, psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, and asthma. This research area highlights involvement in chronic immune-mediated conditions requiring long-term disease control and symptom reduction.
- Multiple sclerosis
- Crohn's disease
- Psoriatic arthritis
- Atopic dermatitis
- Asthma
Additional work includes immune thrombocytopenia, graft-versus-host disease, and autoimmune encephalitis, showing interest in immune dysregulation across neurologic, dermatologic, and hematologic settings.
Neurology and Cognitive Disorders
The investigator is involved in clinical trials addressing Alzheimer's disease, mild cognitive impairment, migraine, neuropathies, and motor neuron disease. This portfolio suggests a focus on progressive neurologic conditions and disorders with unmet therapeutic need.
- Alzheimer's disease
- Mild cognitive impairment
- Multiple sclerosis
- Chronic inflammatory demyelinating polyneuropathy
- Chronic migraine
Other areas include myelin oligodendrocyte glycoprotein antibody-associated disease, multifocal motor neuropathy, and amyotrophic lateral sclerosis, supporting a broad therapeutic interest in central and peripheral nervous system disease.
Cardiometabolic, Renal, and Ophthalmic Conditions
Munachiso Ndukwe also participates in research on heart failure, atherosclerotic cardiovascular disease, hypertriglyceridemia, chronic kidney disease, and IgA nephropathy. These studies reflect engagement with chronic systemic disease and risk reduction across cardiovascular and renal medicine.
- Heart failure
- Atherosclerotic cardiovascular disease
- Chronic kidney disease
- IgA nephropathy
- Diabetic macular edema
Ophthalmic involvement includes diabetic retinopathy, neovascular age-related macular degeneration, and retinal vein occlusion, while infectious and supportive-care interests include recurrent infections and herpes zoster.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.